An engineered cell sheet composed of human islets and human fibroblast, bone marrow–derived mesenchymal stem cells, or adipose–derived mesenchymal stem cells: An in vitro comparison study. Issue 3 (4th May 2018)
- Record Type:
- Journal Article
- Title:
- An engineered cell sheet composed of human islets and human fibroblast, bone marrow–derived mesenchymal stem cells, or adipose–derived mesenchymal stem cells: An in vitro comparison study. Issue 3 (4th May 2018)
- Main Title:
- An engineered cell sheet composed of human islets and human fibroblast, bone marrow–derived mesenchymal stem cells, or adipose–derived mesenchymal stem cells: An in vitro comparison study
- Authors:
- Imamura, Hajime
Adachi, Tomohiko
Kin, Tatsuya
Ono, Shinichiro
Sakai, Yusuke
Adachi, Toshiyuki
Soyama, Akihiko
Hidaka, Masaaki
Takatsuki, Mitsuhisa
Shapiro, A.M. James
Eguchi, Susumu - Abstract:
- ABSTRACT: Background : We previously reported the utility of engineered cell sheets composed of human islets and supporting cells in vitro and in vivo . It is unclear which type of supporting cell is most suitable for constructing cell sheets with human islets. The present study aimed to compare human fibroblasts, bone marrow–derived mesenchymal stem cells (BM–MSCs), and adipose–derived mesenchymal stem cells (ADSCs) as a supporting source for cell sheets. Methods: Engineered cell sheets were fabricated with human islets using human fibroblasts, BM–MSCs, or ADSCs as supporting cells. The islet viability, recovery rate, glucose–stimulated insulin release (determined by the stimulation index), and cytokine secretion (TGF–β1, IL–6, and VEGF) of groups—including an islet–alone group as a control-were compared. Results: All three sheet groups consistently exhibited higher viability, recovery rate, and stimulation index values than the islet-alone group. The ADSC group showed the highest viability and recovery rate among the three sheet groups. There were no discernible differences in the stimulation index values of the groups. The fibroblast group exhibited significantly higher TGF–β1 values in comparison to the other groups. The IL–6 level of the ADSC group was more than five times higher than that of the other groups. The ADSC group showed the VEGF level; however, it did not differ from that of the BM–MSC group to a statistically significant extent. Conclusion: Engineered cellABSTRACT: Background : We previously reported the utility of engineered cell sheets composed of human islets and supporting cells in vitro and in vivo . It is unclear which type of supporting cell is most suitable for constructing cell sheets with human islets. The present study aimed to compare human fibroblasts, bone marrow–derived mesenchymal stem cells (BM–MSCs), and adipose–derived mesenchymal stem cells (ADSCs) as a supporting source for cell sheets. Methods: Engineered cell sheets were fabricated with human islets using human fibroblasts, BM–MSCs, or ADSCs as supporting cells. The islet viability, recovery rate, glucose–stimulated insulin release (determined by the stimulation index), and cytokine secretion (TGF–β1, IL–6, and VEGF) of groups—including an islet–alone group as a control-were compared. Results: All three sheet groups consistently exhibited higher viability, recovery rate, and stimulation index values than the islet-alone group. The ADSC group showed the highest viability and recovery rate among the three sheet groups. There were no discernible differences in the stimulation index values of the groups. The fibroblast group exhibited significantly higher TGF–β1 values in comparison to the other groups. The IL–6 level of the ADSC group was more than five times higher than that of the other groups. The ADSC group showed the VEGF level; however, it did not differ from that of the BM–MSC group to a statistically significant extent. Conclusion: Engineered cell sheets composed of islets and supporting cells had a cytoprotective effect on islets. These results suggest that individual cell types could be a more attractive source for crafting engineered cell sheets in comparison to islets alone. … (more)
- Is Part Of:
- Islets. Volume 10:Issue 3(2018)
- Journal:
- Islets
- Issue:
- Volume 10:Issue 3(2018)
- Issue Display:
- Volume 10, Issue 3 (2018)
- Year:
- 2018
- Volume:
- 10
- Issue:
- 3
- Issue Sort Value:
- 2018-0010-0003-0000
- Page Start:
- Page End:
- Publication Date:
- 2018-05-04
- Subjects:
- Adipose–derived mesenchymal stem cell -- bone marrow–derived mesenchymal stem cell -- cell sheet -- fibroblast -- islet transplantation -- tissue engineering
Islands of Langerhans -- Periodicals
Pancreas -- Periodicals
616.46 - Journal URLs:
- http://www.tandfonline.com/toc/kisl20/current ↗
http://ejournals.ebsco.com/direct.asp?JournalID=718447 ↗
http://www.landesbioscience.com/journals/BioArchitecture ↗
http://www.tandfonline.com/ ↗ - DOI:
- 10.1080/19382014.2018.1445948 ↗
- Languages:
- English
- ISSNs:
- 1938-2022
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 6782.xml